InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Kadysh, Nicholas. Officer active across 1 company, notably Pharmala Biotech Holdings Inc.. Aggregated, 2 disclosures have been logged. History available since 10 June 2026. The latest transaction was disclosed on 10 June 2026 (51 - Exercise of options). Regulator: SEDI. All data is openly available.
2 of 2 declarations